-
Watch List: Nektar Therapeutics (NASDAQ:NKTR), Huntington Bancshares Incorporated (NASDAQ:HBAN), Builders FirstSource (NASDAQ:BLDR), Egalet Corporation (NASDAQ:EGLT), Tesla Motors Inc (NASDAQ:TSLA)
On Monday shares of Nektar Therapeutics (NASDAQ:NKTR) closed at $11.47. Company’s sales growth for last 5 years was 22.80% and EPS growth for next 5 years is recorded as -7.30%. Nektar Therapeutics (NASDAQ:NKTR) on April 30, 2015, declared its financial results for the first quarter ended March 31, 2015. Revenue for the first quarter of…
-
Eye Catching Stocks: Nektar Therapeutics (NASDAQ:NKTR), Bank of America Corporation (NYSE:BAC), REEDS (NYSEMKT:REED), International Business Machines Corporation (NYSE:IBM), Facebook Inc (NASDAQ:FB)
On Friday shares of Nektar Therapeutics (NASDAQ:NKTR) closed at $11.48. Company’s sales growth for last 5 years was 22.80% and EPS growth for next 5 years is recorded as -8.00%. Nektar Therapeutics (NASDAQ:NKTR) on April 30, 2015, announced its financial results for the first quarter ended March 31, 2015. Revenue for the first quarter of…
-
Morning Watch List: Cloud Peak Energy Inc. (NYSE:CLD), Nektar Therapeutics (NASDAQ:NKTR), Skyworks Solutions Inc. (NASDAQ:SWKS), United Security Bancshares (NASDAQ:USBI), SPS Commerce (NASDAQ:SPSC)
On Thursday shares of Cloud Peak Energy Inc. (NYSE:CLD) closed at $6.49. Company’s sales growth for last 5 years was -1.10% and EPS growth for next 5 years is recorded as -3.30%. Cloud Peak Energy Inc. (NYSE:CLD) announced results for the first quarter of 2015. First quarter 2015 Adjusted EBITDA of $39.4 million compared to…
-
Hot Watch List: PAR Technology Corporation (NYSE:PAR), Nektar Therapeutics (NASDAQ:NKTR), Citigroup Inc. (NYSE:C), RE/MAX Holdings (NYSE:RMAX), TriMas Corporation (NASDAQ:TRS)
On Thursday shares of PAR Technology Corporation (NYSE:PAR) closed at $4.15. Company’s sales growth for last 5 years was 1.60% and EPS growth for next 5 years is recorded as 18.00%. PAR Technology Corporation (NYSE:PAR) announced that it will report its first quarter 2015 financial results on Thursday, April 30, 2015. The results are scheduled…
-
Today’s Hot List: Flexible Solutions International Inc. (NYSEMKT:FSI), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO), Voltari Corporation (NASDAQ:VLTC), Linn Co, LLC (NASDAQ:LNCO)
On Thursday shares of Flexible Solutions International Inc. (NYSEMKT:FSI) closed at $1.48. Company’s sales growth for last 5 years was 7.90%. Flexible Solutions International Inc. (NYSEMKT:FSI) announced financial results for the first quarter and full year ended December 31, 2014. Sales for the full year 2014 were $15,907,849, up 1%, when compared to $15,801,596 for…
-
Shining on Major News: China Eastern Airlines Corp. (NYSE:CEA), Nektar Therapeutics (NASDAQ:NKTR), Kite Pharma (NASDAQ:KITE), The Dow Chemical (NYSE:DOW), Google (NASDAQ:GOOG)
On Friday shares of China Eastern Airlines Corp. Ltd. (NYSE:CEA) closed at $28.84. Company’s sales growth for last 5 years was 16.50%. China Eastern Airlines Corp. Ltd. (NYSE:CEA) posted a 45% increase in 2014 profit, as strong growth in air traffic and lower fuel prices more than offset foreign exchange losses. The Shanghai-based carrier said…
-
Whats Hot Today: Asterias Biotherapeutics (NYSEMKT:AST), Capnia (NASDAQ:CAPN), SunEdison (NYSE:SUNE), Oi SA (ADR) (NYSE:OIBR), Nektar Therapeutics (NASDAQ:NKTR)
On Friday shares of Asterias Biotherapeutics, Inc. (NYSEMKT:AST) closed at $7.47. Asterias Biotherapeutics, Inc. (NYSEMKT:AST)’s Pedro Lichtinger, President and Chief Executive Officer of Asterias, presented at the Regen Med Investor Day 2015 Conference at the Metropolitan Club in New York City on March 25, 2015 at 5:05 PM ET/2:05 PM PT. Capnia, Inc. (NASDAQ:CAPN) in…
-
Market Movers: Nektar Therapeutics (NASDAQ:NKTR), CHC Group (NYSE:HELI), Diamondback Energy (NASDAQ:FANG), Boston Properties Inc. (NYSE:BXP), Intersections Inc. (NASDAQ:INTX)
On Wednesday shares of Nektar Therapeutics (NASDAQ:NKTR) closed at $11.02. Company’s sales growth for last 5 years was 22.80% and EPS growth for next 5 years is recorded as -8.00%. Nektar Therapeutics (NASDAQ:NKTR) on March 17, 2015, announced topline results from its Phase 3 BEACON study evaluating single-agent NKTR-102 in patients with advanced breast cancer.…
-
Fast Moving Stocks: Nektar Therapeutics (NASDAQ:NKTR), BIND Therapeutics (NASDAQ:BIND), Taylor Devices Inc. (NASDAQ:TAYD), First Solar (NASDAQ:FSLR), Cognizant Technology Solutions (NASDAQ:CTSH)
On Monday shares of Nektar Therapeutics (NASDAQ:NKTR) closed at $14.07. Company’s sales growth for last 5 years was 22.80% and EPS growth for next 5 years is recorded as 42.50%. JPMorgan Chase & Co. set a $19.00 target price on Nektar Therapeutics (NASDAQ:NKTR) in a report issued on Friday. The firm currently has a buy…